<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1212211463
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZEMENTA 5 mg film-coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MEMANTINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06DX01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>How does&nbsp;Zementa&nbsp;work&nbsp;&nbsp;</p><p>Zementa&nbsp;belongs to a group of medicines known as anti-dementia medicines.&nbsp;&nbsp;</p><p>Memory loss in Alzheimer&rsquo;s disease is due to a disturbance of message signals in the brain. The brain contains so-called N-methyl-D-aspartate (NMDA)-receptors that are involved in transmitting nerve signals important in learning and memory.&nbsp;Zementa&nbsp;belongs to a group of medicines called NMDA-receptor antagonists.&nbsp;Zementa&nbsp;acts on these NMDA-receptors improving the transmission of nerve signals and the memory.&nbsp;&nbsp;</p><p>What is&nbsp;Zementa&nbsp;used for&nbsp;&nbsp;</p><p>Zementa&nbsp;is used for the treatment of patients with moderate to severe Alzheimer&rsquo;s disease.&nbsp;&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take&nbsp;Zementa:&nbsp;</p><ol><li><p>&nbsp;</p></li></ol><ul><li><p>If you are allergic (hypersensitive) to&nbsp;memantine&nbsp;hydrochloride or any of the other ingredients of&nbsp;Zementa&nbsp;tablets (see section 6).&nbsp;&nbsp;</p></li></ul><p>&nbsp;</p><p>Take special care with&nbsp;Zementa&nbsp;&nbsp;</p><ol><li><p>&nbsp;</p></li></ol><ul><li><p>If you have a history of epileptic seizures&nbsp;&nbsp;</p></li><li><p>If you have recently experienced a myocardial infarction (heart attack), or if you are suffering from congestive heart failure or from an uncontrolled hypertension (high blood pressure).&nbsp;&nbsp;</p></li><li><p>In these situations the treatment should be carefully supervised, and the clinical benefit of&nbsp;Zementa&nbsp;reassessed by your doctor on a regular basis.&nbsp;</p></li><li><p>If you suffer from renal impairment (kidney problems), your doctor should closely monitor your kidney function and if necessary adapt the&nbsp;memantine&nbsp;doses accordingly.&nbsp;&nbsp;</p></li></ul><p>The use of medicinal products called amantadine (for the treatment of Parkinson&rsquo;s disease), ketamine (a substance generally used as an&nbsp;anaesthetic), dextromethorphan (generally used to treat cough) and other NMDA-antagonists at the same time should be avoided.&nbsp;&nbsp;</p><p>Zementa&nbsp;is not recommended for children and adolescents under the age of 18 years.&nbsp;&nbsp;</p><p>&nbsp;</p><p>Using other medicines&nbsp;&nbsp;</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.&nbsp;&nbsp;</p><p>In particular,&nbsp;Zementa&nbsp;may change the effects of the following medicines and their dose may need to be adjusted by your doctor:&nbsp;&nbsp;</p><ul><li><p>amantadine, ketamine, dextromethorphan&nbsp;&nbsp;</p></li><li><p>dantrolene, baclofen&nbsp;&nbsp;</p></li><li><p>cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine&nbsp;&nbsp;</p></li><li><p>hydrochlorothiazide (or any combination with hydrochlorothiazide)&nbsp;&nbsp;</p></li></ul><ul><li><p>anticholinergics (substances generally used to treat movement disorders or intestinal cramps)&nbsp;&nbsp;</p></li><li><p>anticonvulsants (substances used to prevent and relieve seizures)&nbsp;&nbsp;</p></li><li><p>barbiturates (substances generally used to induce sleep)&nbsp;&nbsp;</p></li><li><p>dopaminergic agonists (substances such as L-dopa, bromocriptine)&nbsp;&nbsp;</p></li><li><p>neuroleptics (substances used in the treatment of mental disorders)&nbsp;&nbsp;</p></li></ul><ul><li><p>oral anticoagulants&nbsp;&nbsp;</p></li></ul><p>If you go into hospital, let your doctor know that you are taking&nbsp;Zementa.&nbsp;&nbsp;</p><p>&nbsp;</p><p>Taking&nbsp;Zementa&nbsp;with food and drink&nbsp;&nbsp;</p><p>You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal&nbsp;tubulary&nbsp;acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine.&nbsp;&nbsp;</p><p>Pregnancy and breast-feeding&nbsp;&nbsp;</p><ul><li><p>Ask your doctor or pharmacist for advice before taking any medicine.&nbsp;&nbsp;</p></li><li><p>Tell your doctor if you are pregnant or planning to become pregnant. The use of&nbsp;memantine&nbsp;in pregnant women is not recommended.&nbsp;&nbsp;</p></li><li><p>Women taking&nbsp;Zementa&nbsp;should not breast-feed.&nbsp;&nbsp;</p></li></ul><p>Driving and using machines&nbsp;&nbsp;</p><p>Your doctor will tell you whether your illness allows you to drive and to use machines safely.&nbsp;&nbsp;</p><p>Also,&nbsp;Zementa&nbsp;may change your reactivity, making driving or operating machinery inappropriate.&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take&nbsp;Zementa&nbsp;exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.&nbsp;&nbsp;</p><p>&nbsp;</p><p>The recommended dose of&nbsp;Zementa&nbsp;for adults and elderly patients is 20 mg once a day. In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme:&nbsp;</p><p>&nbsp;</p><p>Dosage&nbsp;&nbsp;</p><p>&nbsp;</p><table border="1"><tbody><tr><td><p>week 1&nbsp;&nbsp;</p></td><td><p>Half&nbsp;Zementa&nbsp;10 mg tablet&nbsp;&nbsp;</p></td></tr><tr><td><p>week 2&nbsp;&nbsp;</p></td><td><p>one 10 mg tablet&nbsp;&nbsp;</p></td></tr><tr><td><p>week 3&nbsp;&nbsp;</p></td><td><p>one and a half 10 mg tablets&nbsp;&nbsp;</p></td></tr><tr><td><p>week 4 and beyond&nbsp;</p><p>&nbsp;</p></td><td><p>two 10 mg tablets or one tablet of&nbsp;Zementa&nbsp;20mg once a day&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>The usual starting dose is half a tablet once a day (1x 5 mg) for the first week. This is increased to one tablet once a day (1x 10 mg) in the second week and&nbsp;to 1 and a half tablets once a day in the third week. From the fourth week on, the usual dose is 2 tablets once a day&nbsp;(1x 20 mg).&nbsp;</p><p>&nbsp;</p><p>Dosage in patients with impaired kidney function&nbsp;</p><p>If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.&nbsp;</p><p>&nbsp;</p><p>Administration&nbsp;</p><p>Zementa&nbsp;should be administered orally once a day. To benefit from your medicine you should take it regularly every day at the same time of the day. The tablets should be swallowed with some water. The tablets can be taken with or without food.&nbsp;</p><p>&nbsp;</p><p>Duration of treatment&nbsp;</p><p>Continue to take&nbsp;Zementa&nbsp;as long as it is of benefit to you. Your doctor should assess your treatment on a regular basis.&nbsp;</p><p>&nbsp;</p><p>If you take more&nbsp;Zementa&nbsp;than you should&nbsp;</p><p>- In general, taking too&nbsp;much&nbsp;Zementa&nbsp;should not result in any harm to you. You may experience increased symptoms as described in section 4. &ldquo;Possible side effects&rdquo;.&nbsp;</p><p>- If you take a large overdose of&nbsp;Zementa, contact your doctor or get medical advice, as you may need medical attention.&nbsp;</p><p>&nbsp;</p><p>If you forget to take&nbsp;Zementa&nbsp;</p><p>- If you find you have forgotten to take your dose of&nbsp;Zementa, wait and take your next dose at the usual time.&nbsp;</p><p>- Do not take a double dose to make up for a forgotten dose.&nbsp;</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor&nbsp;or pharmacist.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines,&nbsp;Zementa&nbsp;can cause side effects, although not everybody gets them.&nbsp;&nbsp;</p><p>In general, the observed side effects are mild to moderate.&nbsp;&nbsp;</p><p>&nbsp;</p><p>Common (affects 1 to 10 users in 100):&nbsp;&nbsp;</p><p>&nbsp;</p><p>Headache, sleepiness, constipation, elevated liver function tests, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity&nbsp;&nbsp;</p><p>&nbsp;</p><p>Uncommon (affects 1 to 10 users in 1,000):&nbsp;&nbsp;</p><p>&nbsp;</p><p>Tiredness, fungal infections, confusion, hallucinations, vomiting, abnormal gait, heart failure and venous blood clotting (thrombosis/thromboembolism)&nbsp;&nbsp;</p><p>&nbsp;</p><p>Very Rare (affects less than 1 user in 10,000):&nbsp;&nbsp;</p><p>&nbsp;</p><p>Seizures&nbsp;&nbsp;</p><p>&nbsp;</p><p>Not known (frequency cannot be estimated from the available data):&nbsp;&nbsp;</p><p>&nbsp;</p><p>Inflammation of the pancreas, inflammation of the liver (hepatitis) and psychotic reactions&nbsp;&nbsp;</p><p>&nbsp;</p><p>Alzheimer&rsquo;s disease has been associated with depression, suicidal ideation and suicide. These events have been reported in patients treated with&nbsp;Zementa.&nbsp;&nbsp;</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,&nbsp;please tell your doctor or pharmacist.&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li><p>Keep out of the reach and sight of children.&nbsp;&nbsp;</p></li><li><p>Do not use&nbsp;Zementa&nbsp;after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.&nbsp;&nbsp;</p></li><li><p>Do not store above 30&deg;C.&nbsp;</p></li><li><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.&nbsp;&nbsp;</p></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is&nbsp;memantine&nbsp;hydrochloride.&nbsp;&nbsp;</p><p>Each 5mg film-coated tablet contains 5 mg&nbsp;memantine&nbsp;hydrochloride.&nbsp;</p><p>The other ingredients are:&nbsp;</p><p>Tablet core: Microcrystalline Cellulose (Avicel&nbsp;pH 102), Lactose NF Fast Flow,&nbsp;Croscarmellose&nbsp;Sodium Type A, Colloidal Silicon Dioxide&nbsp;</p><p>Tablet coating:&nbsp;Hydroxypropyl&nbsp;Methylcellulose, Titanium Dioxide pharma grade, Purified Talc, Polyethylene Glycol MW 6000, Purified Water (10mg) Iron Oxide Yellow, (20mg) Iron Oxide Red&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ZEMENTA tablet is a film-coated tablet: 

ZEMENTA 5mg: A white, round, biconvex film-coated tablet, engraved with number "9" on one side and plain surface on the other side. 
ZEMENTA film-coated tablets are supplied in cartons containing 30 film-coated tablets per pack. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO&nbsp;</p><p>Al-Qassim&nbsp;pharmaceutical plant&nbsp;</p><p>Saudi Pharmaceutical Industries &amp;&nbsp;</p><p>Medical Appliance Corporation&nbsp;</p><p>Saudi Arabia&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                May 2017 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>كيف&nbsp;يعمل&nbsp;زيمينتا&nbsp;</p><p>ينتمى&nbsp;زيمينتا&nbsp;إلى&nbsp;مجموعة&nbsp;من&nbsp;الأدوية&nbsp;تعرف&nbsp;بمضادات&nbsp;الخرف.&nbsp;</p><p>يحدث&nbsp;فقدان&nbsp;الذاكرة&nbsp;فى&nbsp;مرض&nbsp;الزهايمر&nbsp;نتيجة&nbsp;إلى&nbsp;اضطراب&nbsp;إشارات&nbsp;الرسائل&nbsp;في&nbsp;الدماغ.&nbsp;يحتوي&nbsp;الدماغ&nbsp;على&nbsp;ما&nbsp;يسمى&nbsp;مستقبلات&nbsp;إن&nbsp;ميثيل&nbsp;دى&nbsp;أسبارتات&nbsp;NMDA))&nbsp;التي&nbsp;تشارك&nbsp;في&nbsp;نقل&nbsp;الإشارات&nbsp;العصبية&nbsp;الهامة&nbsp;في&nbsp;التعلم&nbsp;والذاكرة.ينتمى&nbsp;زيمينتا&nbsp;إلى&nbsp;مجموعة&nbsp;من&nbsp;الأدوية&nbsp;التى&nbsp;تسمى&nbsp;مضادات&nbsp;مستقبلات&nbsp;NMDA)).&nbsp;يعمل&nbsp;زيمينتا&nbsp;على&nbsp;هذه&nbsp;المستقبلات&nbsp;مما&nbsp;يحسن&nbsp;من&nbsp;نقل&nbsp;الإشارات&nbsp;العصبية&nbsp;و&nbsp;يحسن&nbsp;الذاكرة.&nbsp;</p><p>فيم&nbsp;تستخدم&nbsp;زيمينتا&nbsp;</p><p>يستخدم&nbsp;زيمينتا&nbsp;لعلاج&nbsp;المرضى&nbsp;المصابين&nbsp;بمرض&nbsp;الزهايمر&nbsp;من&nbsp;الدرجة&nbsp;المتوسطة&nbsp;إلى&nbsp;الشديدة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا&nbsp;تتناول&nbsp;زيمينتا:&nbsp;</p><ul><li><p>إذا&nbsp;كان&nbsp;لديك&nbsp;حساسية&nbsp;زائدة&nbsp;تجاه&nbsp;ميمانتين&nbsp;هيدروكلورايد&nbsp;أو&nbsp;أى&nbsp;مكون&nbsp;آخر&nbsp;من&nbsp;مكونات&nbsp;أقراص&nbsp;زيمينتا&nbsp;(أنظر&nbsp;فقرة&nbsp;6)&nbsp;</p></li></ul><p>ينبغى&nbsp;توخى&nbsp;الحذرمع&nbsp;زيمينتا:&nbsp;</p><ul><li><p>إذا&nbsp;كان&nbsp;لديك&nbsp;تاريخ&nbsp;من&nbsp;نوبات&nbsp;الصرع.&nbsp;</p></li><li><p>إذا&nbsp;كنت&nbsp;قد&nbsp;تعرضت&nbsp;مؤخرا&nbsp;لإحتشاء&nbsp;عضلة&nbsp;القلب&nbsp;(نوبة&nbsp;قلبية)، أو&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;فشل&nbsp;القلب&nbsp;الاحتقاني&nbsp;أو&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم&nbsp;غير&nbsp;المنضبط&nbsp;(ارتفاع&nbsp;ضغط&nbsp;الدم).&nbsp;</p></li><li><p>وفي&nbsp;هذه&nbsp;الحالات&nbsp;ينبغي&nbsp;أن&nbsp;يكون&nbsp;العلاج&nbsp;تحت&nbsp;الإشراف&nbsp;بعناية&nbsp;فائقة، وإعادة&nbsp;تقييم&nbsp;الفائدة&nbsp;السريرية&nbsp;من&nbsp;زيمينتا&nbsp;من&nbsp;قبل&nbsp;الطبيب&nbsp;على&nbsp;أساس&nbsp;منتظم.&nbsp;</p></li><li><p>إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;اختلال&nbsp;كلوي&nbsp;(مشاكل&nbsp;في&nbsp;الكليتين)، وينبغي&nbsp;أن&nbsp;يراقب&nbsp;طبيبك&nbsp;وظائف&nbsp;الكلى&nbsp;الخاصة&nbsp;بك&nbsp;عن&nbsp;كثب&nbsp;وإذا&nbsp;لزم&nbsp;الأمر&nbsp;تعديل&nbsp;جرعات&nbsp;ميمانتين&nbsp;وفقا&nbsp;لذلك.&nbsp;</p></li></ul><p>ينبغى&nbsp;تجنب&nbsp;استخدام&nbsp;أدوية&nbsp;تدعى&nbsp;أمانتادين&nbsp;(لعلاج&nbsp;مرض&nbsp;الشلل&nbsp;الرعاش)، و&nbsp;كيتامين&nbsp;(وهي&nbsp;مادة&nbsp;تستخدم&nbsp;عادة&nbsp;كمخدر)، ديكسترومثورفان&nbsp;(تستخدم&nbsp;عادة&nbsp;لعلاج&nbsp;السعال)&nbsp;وغيرها&nbsp;من&nbsp;مضادات&nbsp;NMDA&nbsp;في&nbsp;نفس&nbsp;الوقت.&nbsp;</p><p>لا&nbsp;ينصح&nbsp;زيمينتا&nbsp;للأطفال&nbsp;والمراهقين&nbsp;الذين&nbsp;تقل&nbsp;أعمارهم&nbsp;عن&nbsp;18&nbsp;عاما.&nbsp;</p><p>استخدام&nbsp;أدوية&nbsp;أخرى&nbsp;</p><p>&nbsp;يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت في الآونة الأخيرة أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.&nbsp;</p><p>على&nbsp;وجه&nbsp;الخصوص، قد&nbsp;يغير&nbsp;زيمينتا&nbsp;من&nbsp;تأثير&nbsp;الأدوية&nbsp;التالية&nbsp;و&nbsp;قد&nbsp;يحتاج&nbsp;طبيبك&nbsp;إلى&nbsp;تعديل&nbsp;جرعاتها:&nbsp;</p><ul><li><p>أمانتادين&nbsp;و&nbsp;كيتامين&nbsp;و&nbsp;ديكستروميثورفان&nbsp;</p></li></ul><ul><li><p>دانترولين&nbsp;و&nbsp;باكلوفين&nbsp;</p></li><li><p>سايميتيدين&nbsp;و&nbsp;رادنتيدين&nbsp;و&nbsp;بركاينامايد&nbsp;و&nbsp;كينيدين&nbsp;وكينين&nbsp;و&nbsp;نيكوتين&nbsp;</p></li><li><p>هايدروكلوروثيازايد&nbsp;(أو&nbsp;أى&nbsp;مركب&nbsp;يحتوى&nbsp;على&nbsp;هيدروكلوروثيازايد)&nbsp;</p></li><li><p>مضادات&nbsp;الكولين&nbsp;(أدوية&nbsp;تستخدم&nbsp;عادة&nbsp;لعلاج&nbsp;اضطرابات&nbsp;الحركة&nbsp;أو&nbsp;تقلصات&nbsp;الأمعاء)&nbsp;</p></li><li><p>مضادات&nbsp;التشنجات&nbsp;(أدوية&nbsp;تمنع&nbsp;أو&nbsp;تخفف&nbsp;التشنجات)&nbsp;</p></li></ul><ul><li><p>باربيتورات&nbsp;(أدوية&nbsp;تستخدم&nbsp;عادة&nbsp;للحث&nbsp;على&nbsp;النوم)&nbsp;</p></li><li><p>محفزات&nbsp;الدوبامين&nbsp;(أدوية&nbsp;مثل&nbsp;ل-&nbsp;دوبا&nbsp;و&nbsp;بروموكريبتين)&nbsp;</p></li><li><p>مضادات&nbsp;الذهان&nbsp;(أدوية&nbsp;تستخدم&nbsp;لعلاج&nbsp;الأمراض&nbsp;العقلية)&nbsp;</p></li><li><p>مضادات&nbsp;التجلط&nbsp;الفموية&nbsp;</p></li></ul><p>إذا&nbsp;ذهبت&nbsp;إلى&nbsp;المستشفى، اعلم&nbsp;طبيبك&nbsp;أنك&nbsp;تتناول&nbsp;زيمينتا.&nbsp;</p><p>تناول&nbsp;زيمينتا&nbsp;مع&nbsp;الطعام&nbsp;و&nbsp;الشراب&nbsp;</p><p>يجب&nbsp;عليك&nbsp;إبلاغ&nbsp;الطبيب&nbsp;إذا&nbsp;كنت&nbsp;قد&nbsp;غيرت&nbsp;مؤخرا&nbsp;أو&nbsp;تنوي&nbsp;تغيير&nbsp;النظام&nbsp;الغذائي&nbsp;الخاص&nbsp;بك&nbsp;بشكل&nbsp;كبير&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;من&nbsp;النظام&nbsp;الغذائي&nbsp;العادي&nbsp;إلى&nbsp;نظام&nbsp;غذائي&nbsp;نباتي&nbsp;صارم)&nbsp;أو&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;حالات&nbsp;الحماض&nbsp;الأنبوبى&nbsp;الكلوي&nbsp;(RTA)&nbsp;وهو&nbsp;وجود&nbsp;فائض&nbsp;من&nbsp;المواد&nbsp;الحمضية&nbsp;المكونة&nbsp;في&nbsp;الدم&nbsp;بسبب&nbsp;الفشل&nbsp;الكلوي&nbsp;(فقر&nbsp;وظيفة&nbsp;الكلى)&nbsp;أو&nbsp;التهاب&nbsp;حاد&nbsp;في&nbsp;المسالك&nbsp;البولية&nbsp;(الهيكل&nbsp;الذي&nbsp;يحمل&nbsp;البول)، والطبيب&nbsp;قد&nbsp;يحتاج&nbsp;إلى&nbsp;تعديل&nbsp;جرعة&nbsp;الدواء.&nbsp;</p><p>الحمل&nbsp;و&nbsp;الرضاعة&nbsp;</p><ul><li><p>اسأل&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;للحصول&nbsp;على&nbsp;المشورة&nbsp;قبل&nbsp;تناول&nbsp;أي&nbsp;دواء.&nbsp;</p></li><li><p>أخبرى&nbsp;طبيبك&nbsp;إذا&nbsp;كنتى&nbsp;حاملا&nbsp;أو&nbsp;تخططين&nbsp;للحمل.&nbsp;لا&nbsp;ينصح&nbsp;استخدام&nbsp;النساء&nbsp;الحوامل&nbsp;لميمانتين.&nbsp;</p></li></ul><ul><li><p>لا&nbsp;ينبغى&nbsp;إرضاع&nbsp;طفلك&nbsp;طبيعيا&nbsp;إذا&nbsp;كنتى&nbsp;تتناولين&nbsp;زيمينتا.&nbsp;</p></li></ul><p>القيادة واستخدام الآلات&nbsp;</p><p>طبيبك&nbsp;سوف&nbsp;يخبرك&nbsp;ما&nbsp;اذا&nbsp;كان&nbsp;مرضك&nbsp;يسمح&nbsp;لك&nbsp;بالقيادة&nbsp;واستخدام&nbsp;الآلات&nbsp;بأمان.&nbsp;</p><p>أيضا، قد&nbsp;يغير&nbsp;زيمينتا&nbsp;ردة&nbsp;فعلك، مما&nbsp;يجعل&nbsp;القيادة&nbsp;أو&nbsp;تشغيل&nbsp;الآلات&nbsp;غير&nbsp;لائق.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم دائما بتناول أقراص&nbsp;زيمينتا&nbsp;تماما كما أخبرك الطبيب المعالج. إذا كنت غير واثق يجب عليك التحقق من خلال الطبيب أو الصيدلى.&nbsp;</p><p>الجرعة الموصى بها من زيمينتا للكبار والمرضى كبار السن هي 20 ملجم مرة واحدة يوميا. من أجل الحد من خطر الآثار الجانبية ويتم الوصول إلى هذه الجرعة تدريجيا بمخطط العلاج اليومي التالى:&nbsp;</p><p>الجرعة&nbsp;</p><table border="1"><tbody><tr><td><p>نصف قرص&nbsp;زيمينتا&nbsp;10 ملجم&nbsp;</p></td><td><p>الأسبوع الأول&nbsp;</p></td></tr><tr><td><p>قرص&nbsp;زيمينتا&nbsp;10 ملجم&nbsp;</p></td><td><p>الأسبوع الثانى&nbsp;</p></td></tr><tr><td><p>قرص و نصف من&nbsp;زيمينتا&nbsp;10 ملجم&nbsp;</p></td><td><p>الأسبوع الثالث&nbsp;</p></td></tr><tr><td><p>قرصين&nbsp;زيمينتا&nbsp;10 ملجم مرة يوميا أو قرص من&nbsp;زيمينتا 20 ملجم&nbsp;</p></td><td><p>الأسبوع الرابع و باقى فترة العلاج&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>الجرعة المعتادة&nbsp;المبدئية&nbsp;هي نصف قرص مرة واحدة يوميا (1&nbsp;X5&nbsp;ملجم) في الأسبوع الأول. يتم زيادة هذا إلى قرص واحد مرة واحدة يوميا (1&nbsp;X10&nbsp;ملجم) في الأسبوع الثاني وقرص ونصف مرة واحدة في اليوم في الأسبوع الثالث. من الأسبوع الرابع&nbsp;و باقى فترة العلاج، الجرعة المعتادة هي 2 حبة مرة واحدة يوميا (1&nbsp;X20&nbsp;ملجم).&nbsp;</p><p>الجرعة في المرضى الذين يعانون من خلل&nbsp;فى&nbsp;وظائف الكلى&nbsp;</p><p>إذا كان لديك خلل&nbsp;فى&nbsp;وظائف الكلى، و&nbsp;سوف&nbsp;يقرر الطبيب&nbsp;الجرعة التي تناسب حالتك. في هذه الحالة، يجب القيام&nbsp;بمراقبة وظيفة الكلى الخاصة بك من قبل الطبيب على فترات زمنية محددة.&nbsp;</p><p>التناول&nbsp;</p><p>ينبغي أن&nbsp;تتناول&nbsp;زيمينتا&nbsp;عن طريق الفم مرة واحدة يوميا. للاستفادة من الدواء يجب أن&nbsp;تتناوله&nbsp;بانتظام كل يوم في نفس الوقت من اليوم. يجب ابتلاع الأقراص مع بعض الماء. يمكن&nbsp;تناول&nbsp;الأقراص مع أو بدون الطعام.&nbsp;</p><p>مدة العلاج&nbsp;</p><p>استمر في تناول&nbsp;زيمينتا&nbsp;طالما أنه&nbsp;يفيدك. يجب على طبيبك أن يقيم علاجك بشكل منتظم.&nbsp;</p><p>إذا&nbsp;تتناولت&nbsp;من&nbsp;زيمينتا&nbsp;أكثر&nbsp;مما يجب&nbsp;</p><p>- بشكل عام، لا ينبغي أن يؤدي&nbsp;تناول&nbsp;الكثير من&nbsp;زيمينتا&nbsp;إلى أي ضرر لك. قد تواجه أعراض&nbsp;متزايدة&nbsp;كما هو موضح في الفقرة 4. &quot;الأعراض&nbsp;الجانبية المحتملة&quot;.&nbsp;</p><p>- إذا&nbsp;تناولت&nbsp;جرعة زائدة كبيرة من&nbsp;زيمينتا&nbsp;، اتصل بطبيبك أو احصل على المشورة الطبية، كما قد تحتاج إلى عناية طبية.&nbsp;</p><p>&nbsp;</p><p>إذا كنت قد نسيت أن&nbsp;تتناول&nbsp;زيمينتا&nbsp;</p><p>- إذا وجدت أنك قد نسيت أن&nbsp;تتناول&nbsp;جرعة من&nbsp;زيمينتا&nbsp;،&nbsp;انتظر وخذ الجرعة التالية في الوقت المعتاد.&nbsp;</p><p>- لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.&nbsp;</p><p>إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، زيمينتا قد يسبب أعراض جانبية، وإن لم تكن تحدث لكل من يتناول هذا الدواء.&nbsp;</p><p>بشكل عام، الآثار الجانبية الملحوظة خفيفة إلى متوسطة.&nbsp;</p><p>&nbsp;</p><p>شائعة (تؤثر 1-10 مستخدمين في 100):&nbsp;</p><p>&nbsp;</p><p>الصداع، والنعاس، والإمساك، ارتفاع فى تحاليل وظائف الكبد، والدوخة، واضطرابات في التوازن، وضيق في التنفس، وارتفاع ضغط الدم وفرط الحساسية للدواء&nbsp;</p><p>&nbsp;</p><p>غير شائعة (تؤثر 1-10 مستخدمين في 1000):&nbsp;</p><p>&nbsp;</p><p>التعب، والعدوى الفطرية، والارتباك، والهلوسة، والتقيؤ، ومشية غير طبيعية، وفشل القلب وتجلط الدم الوريدي (الجلطة / الجلطات الدموية)&nbsp;</p><p>&nbsp;</p><p>نادرة&nbsp;جدا&nbsp;(تؤثر&nbsp;فى&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;فى&nbsp;10000):&nbsp;</p><p>&nbsp;</p><p>النوبات&nbsp;</p><p>&nbsp;</p><p>غير&nbsp;معروف&nbsp;(لا&nbsp;يمكن&nbsp;تقدير&nbsp;تردد&nbsp;من&nbsp;البيانات&nbsp;المتاحة):&nbsp;</p><p>&nbsp;</p><p>التهاب&nbsp;البنكرياس، التهاب&nbsp;الكبد&nbsp;(التهاب&nbsp;الكبد)&nbsp;وردود&nbsp;الفعل&nbsp;الذهانية&nbsp;</p><p>ارتبط&nbsp;مرض&nbsp;الزهايمر&nbsp;بالإكتئاب، التفكير&nbsp;في&nbsp;الإنتحار&nbsp;والإنتحار.&nbsp;وقد&nbsp;تم&nbsp;الإبلاغ&nbsp;عن&nbsp;هذه&nbsp;الأحداث&nbsp;في&nbsp;المرضى&nbsp;الذين&nbsp;تناولوا&nbsp;زيمينتا.&nbsp;</p><p>إذا لاحظت أن أيا من هذه الأعراض الجانبية أصبح جسيما،&nbsp; أو إذا لاحظت ظهور أى أعراض جانبية لم ترد فى هذه النشرة فإنه يرجى أن تخبر طبيبك المعالج أو الصيدلى الذى تتعامل معه بشأنها.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li><p>يحفظ الدواء بعيدا عن متناول ونظر الأطفال.&nbsp;</p></li><li><p>لا تستعمل زيمينتا بعد انتهاء تاريخ الصلاحية المدون على العبوة. وتاريخ الإنتهاء يشير إلى أخر يوم فى الشهر&nbsp;المذكور.&nbsp;</p></li></ul><ul><li><p>لا يحفظ في درجة حرارة أعلى من 30 درجة مئوية.&nbsp;</p></li><li><p>يجب عدم التخلص من الأدوية في مياه المجاري أو قمامة المنزل. اسأل الصيدلي كيف تتخلص من الأدوية التي لم تعد بحاجتها. لأن هذه الاعتبارات ستعمل على حماية البيئة.&nbsp;</p></li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هى ميمانتين هيدروكلورايد.&nbsp;</p><p>يحتوى كل قرص من زيمينتا 5 ملجم مغلف بطبقة رقيقة على 5 ملجم من ميمانتين هيدروكلورايد.&nbsp;</p><p>المكونات الأخرى:&nbsp;</p><p>لب&nbsp;القرص:&nbsp;ميكروكريستالين&nbsp;السليلوز&nbsp;(أفسيل&nbsp;بى&nbsp;إتش 102)، لاكتوز&nbsp;NF&nbsp;تدفق&nbsp;سريع، كروزكارميللوز&nbsp;صوديوم&nbsp;نوع&nbsp;A، ثاني&nbsp;أكسيد&nbsp;السيليكون&nbsp;الغرواني&nbsp;</p><p>طلاء&nbsp;القرص:&nbsp;هيدروكسي&nbsp;بروبيل&nbsp;ميثيل&nbsp;سيلليولوز، ثاني&nbsp;أكسيد&nbsp;التيتانيوم&nbsp;فارما&nbsp;الصف، و&nbsp;تلك&nbsp;منقى ، والبولي&nbsp;إيثلين&nbsp;جلايكول&nbsp;MW&nbsp;6000، والمياه&nbsp;النقية&nbsp;(10&nbsp;ملجم)&nbsp;أكسيد&nbsp;الحديد&nbsp;الأصفر، (20 ملجم)&nbsp;أكسيد&nbsp;الحديد&nbsp;الأحمر&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>زيمينتا أقراص مغلفة بطبقة رقيقة قرص زيمينتا 5 ملجم هو قرص أبيض، مستدير، قرص ثنائي التحدب مغلف بطبقة رقيقة، محفور &quot;9&quot; على أحد السطحين و عادي على السطح الآخر. تتوفر أقراص زيمينتا فى عبوة تحتوى كل عبوة على 30 قرص مغلف بطبقة رقيقة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الدوائية&nbsp;</p><p>مصنع الأدوية بالقصيم&nbsp;</p><p>الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.&nbsp;</p><p>المملكة العربية السعودية&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مايو 2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zementa 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 5 mg film-coated tablet contains 5 mg of memantine hydrochloride. 
 

Each 10 mg film-coated tablet contains 10 mg of memantine hydrochloride. 
 

Each 20 mg film-coated tablet contains 20 mg of memantine hydrochloride. 
 

For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet 

Zementa 5 mg film-coated tablets 

A white, round, biconvex film-coated tablet, engraved with number "9" on one side and plain surface on the other side. 

Zementa 10 mg film-coated tablets 

A yellow, capsule-shaped, biconvex film-coated tablet, engraved with number "225" on one side and a score on the other side. 

Zementa 20 mg film-coated tablets 

A pink, capsule-shaped, biconvex film-coated tablet, engraved with number "226" on one side and plain surface on the other side. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of adult patients with moderate to severe Alzheimer&#39;s disease.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer&#39;s dementia.&nbsp;</p><p>Posology&nbsp;</p><p>Therapy should only be started if a caregiver is available who will regularly monitor the intake of the medicinal product by the patient. Diagnosis should be made according to current guidelines. The tolerance and dosing of&nbsp;memantine&nbsp;should be reassessed on a regular basis, preferably within three months after start of treatment. Thereafter, the clinical benefit of&nbsp;memantine&nbsp;and the patient&#39;s tolerance of treatment should be reassessed on a regular basis according to current clinical guidelines. Maintenance treatment can be continued for as long as a therapeutic benefit is&nbsp;favourable&nbsp;and the patient tolerates treatment with&nbsp;memantine. Discontinuation of&nbsp;memantine&nbsp;should be considered when evidence of a therapeutic effect is no longer present or if the patient does not tolerate treatment.&nbsp;</p><p>Adults:&nbsp;</p><p>Dose titration&nbsp;</p><p>The maximum daily dose is 20 mg per day. In order to reduce the risk of undesirable effects, the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows:&nbsp;</p><p>Week 1 (day 1-7)&nbsp;</p><p>The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days.&nbsp;</p><p>Week 2 (day 8-14)&nbsp;</p><p>The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days.&nbsp;</p><p>Week 3 (day 15-21):&nbsp;</p><p>The patient should take one and a half 10 mg film-coated tablets (15 mg) per day for 7 days.&nbsp;</p><p>From Week 4 on:&nbsp;</p><p>The patient should take two 10 mg film-coated tablets (20 mg) or one 20 mg film-coated tablet per day.&nbsp;</p><p>Maintenance dose&nbsp;</p><p>The recommended maintenance dose is 20 mg per day.&nbsp;</p><p>Elderly&nbsp;</p><p>On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg film-coated tablets or one 20 mg film-coated tablet once a day) as described above.&nbsp;</p><p>Renal impairment&nbsp;</p><p>In patients with mildly impaired renal function (creatinine clearance 50 &ndash; 80 ml/min) no dose adjustment is required. In patients with moderate renal impairment (creatinine clearance 30 &ndash; 49 ml/min) daily dose should be 10 mg per day. If tolerated well after at least 7 days of treatment, the dose could be increased up to 20 mg/day according to standard titration scheme. In patients with severe renal impairment (creatinine clearance 5 &ndash; 29 ml/min) daily dose should be 10 mg per day.&nbsp;</p><p>Hepatic impairment&nbsp;</p><p>In patients with mild or moderate hepatic impaired function (Child-Pugh A and Child-Pugh B), no dose adjustment is needed. No data on the use of&nbsp;memantine&nbsp;in patients with severe hepatic impairment are available. Administration of&nbsp;Zementa&nbsp;is not recommended in patients with severe hepatic impairment.&nbsp;</p><p>Paediatric&nbsp;population&nbsp;</p><p>No data available.&nbsp;</p><p>Method of administration&nbsp;</p><p>Zementa&nbsp;should be administered orally once a day and should be taken at the same time every day. The film-coated tablets can be taken with or without food.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Caution is recommended in patients with epilepsy, former history of convulsions or patients with predisposing factors for epilepsy.&nbsp;</p><p>Concomitant use of N-methyl-D-aspartate (NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided. These compounds act at the same receptor system as&nbsp;memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related) may be more frequent or more pronounced (see also section 4.5).&nbsp;</p><p>Some factors that may raise urine pH (see section 5.2 &ldquo;Elimination&rdquo;) may necessitate careful monitoring of the patient. These factors include drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or a massive ingestion of&nbsp;alkalising&nbsp;gastric buffers. Also, urine pH may be elevated by states of renal&nbsp;tubulary&nbsp;acidosis (RTA) or severe infections of the urinary tract with Proteus bacteria.&nbsp;</p><p>In most clinical trials, patients with recent myocardial infarction, uncompensated congestive heart failure (NYHA III-IV), or uncontrolled hypertension were excluded. As a consequence, only limited data are available and patients with these conditions should be closely supervised.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the pharmacological effects and the mechanism of action of&nbsp;memantine&nbsp;the following interactions may occur:&nbsp;</p><p>&bull; The mode of action suggests that the effects of L-dopa, dopaminergic agonists, and anticholinergics may be enhanced by concomitant treatment with NMDA-antagonists such as&nbsp;memantine. The effects of barbiturates and neuroleptics may be reduced. Concomitant administration of&nbsp;memantine&nbsp;with the antispasmodic agents,&nbsp;dantrolene&nbsp;or baclofen, can modify their effects and a dose adjustment may be necessary.&nbsp;</p><p>&bull; Concomitant use of&nbsp;memantine&nbsp;and amantadine should be avoided, owing to the risk of&nbsp;pharmacotoxic&nbsp;psychosis. Both compounds are chemically related NMDA-antagonists. The same may be true for ketamine and dextromethorphan (see also section 4.4). There is one published case report on a possible risk also for the combination of&nbsp;memantine&nbsp;and phenytoin.&nbsp;</p><p>&bull; Other active substances such as cimetidine, ranitidine, procainamide, quinidine, quinine and nicotine that use the same renal cationic transport system as amantadine may also possibly interact with&nbsp;memantine&nbsp;leading to a potential risk of increased plasma levels.&nbsp;</p><p>&bull; There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when&nbsp;memantine&nbsp;is co-administered with HCT or any combination with HCT.&nbsp;</p><p>&bull; In post-marketing experience, isolated cases with international normalized ratio (INR) increases have been reported in patients concomitantly treated with warfarin. Although no causal relationship has been established, close monitoring of prothrombin time or INR is advisable for patients concomitantly treated with oral anticoagulants.&nbsp;</p><p>In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance-active substance interaction of&nbsp;memantine&nbsp;with glyburide/metformin or donepezil was observed.&nbsp;</p><p>In a clinical study in young healthy subjects, no relevant effect of&nbsp;memantine&nbsp;on the pharmacokinetics of&nbsp;galantamine&nbsp;was observed.&nbsp;</p><p>Memantine&nbsp;did not inhibit CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A,&nbsp;flavin&nbsp;containing monooxygenase, epoxide hydrolase or&nbsp;sulphation in vitro.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy&nbsp;</p><p>Pregnancy Category: C&nbsp;</p><p>There are no or limited amount of data from the use of&nbsp;memantine&nbsp;in pregnant women. Animal studies indicate a potential for reducing intrauterine growth at exposure levels, which are identical or slightly higher than at human exposure (see section 5.3). The potential risk for humans is unknown.&nbsp;Memantine&nbsp;should not be used during pregnancy unless clearly necessary.&nbsp;</p><p>Breast-feeding&nbsp;</p><p>It is not known whether&nbsp;memantine&nbsp;is excreted in human breast milk but, taking into consideration the lipophilicity of the substance, this probably occurs. Women taking&nbsp;memantine&nbsp;should not breast-feed.&nbsp;</p><p>Fertility&nbsp;</p><p>No adverse reactions of&nbsp;memantine&nbsp;were noted on male and female fertility.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Moderate to severe Alzheimer&#39;s disease usually causes impairment of driving performance and compromises the ability to use machinery. Furthermore,&nbsp;Zementa&nbsp;has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile&nbsp;</p><p>In clinical trials in mild to severe dementia, involving 1,784 patients treated with&nbsp;Zementa&nbsp;and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with&nbsp;Zementa&nbsp;did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity. The most frequently occurring adverse reactions with a higher incidence in the&nbsp;Zementa&nbsp;group than in the placebo group were dizziness (6.3% vs 5.6%, respectively), headache (5.2% vs 3.9%), constipation (4.6% vs 2.6%), somnolence (3.4% vs 2.2%) and hypertension (4.1% vs 2.8%).&nbsp;</p><p>Tabulated list of adverse reactions&nbsp;</p><p>The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with&nbsp;Zementa&nbsp;and since its introduction in the market.&nbsp;</p><p>Adverse reactions are ranked according to system organ class, using the following convention: very common (&ge;1/10), common (&ge;1/100 to &lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100), rare (&ge;1/10,000 to &lt; 1/1,000), very rare (&lt; 1/10,000), not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.&nbsp;</p><table border="1"><tbody><tr><td><p>SYSTEM ORGAN CLASS&nbsp;</p></td><td><p>FREQUENCY&nbsp;</p></td><td><p>ADVERSE REACTION&nbsp;</p></td></tr><tr><td><p>Infections and infestations&nbsp;</p></td><td><p>Uncommon&nbsp;</p></td><td><p>Fungal infections&nbsp;</p></td></tr><tr><td><p>Immune system disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Drug hypersensitivity&nbsp;</p></td></tr><tr><td rowspan="4" colspan="1"><p>Psychiatric disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Somnolence&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Confusion&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Hallucinations1&nbsp;</p></td></tr><tr><td><p>Not known&nbsp;</p></td><td><p>Psychotic reactions2&nbsp;</p></td></tr><tr><td rowspan="4" colspan="1"><p>Nervous system disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Dizziness&nbsp;</p></td></tr><tr><td><p>Common&nbsp;</p></td><td><p>Balance disorders&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Gait abnormal&nbsp;</p></td></tr><tr><td><p>Very rare&nbsp;</p></td><td><p>Seizures&nbsp;</p></td></tr><tr><td><p>Cardiac disorders&nbsp;</p></td><td><p>Uncommon&nbsp;</p></td><td><p>Cardiac failure&nbsp;</p></td></tr><tr><td><p>&nbsp;</p></td><td><p>Not known&nbsp;</p></td><td><p>Bradyarrhythmia&nbsp;</p></td></tr><tr><td rowspan="2" colspan="1"><p>Vascular disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Hypertension&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Venous thrombosis/thromboembolism&nbsp;</p></td></tr><tr><td><p>Respiratory, thoracic and mediastinal disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Dyspnoea&nbsp;</p></td></tr><tr><td rowspan="3" colspan="1"><p>Gastrointestinal disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Constipation&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Vomiting&nbsp;</p></td></tr><tr><td><p>Not known&nbsp;</p></td><td><p>Pancreatitis2&nbsp;</p></td></tr><tr><td rowspan="2" colspan="1"><p>Hepatobiliary disorders&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Elevated liver function test&nbsp;</p></td></tr><tr><td><p>Not known&nbsp;</p></td><td><p>Hepatitis&nbsp;</p></td></tr><tr><td rowspan="2" colspan="1"><p>General disorders and administration site conditions&nbsp;</p></td><td><p>Common&nbsp;</p></td><td><p>Headache&nbsp;</p></td></tr><tr><td><p>Uncommon&nbsp;</p></td><td><p>Fatigue&nbsp;</p></td></tr></tbody></table><p>1 Hallucinations have mainly been observed in patients with severe Alzheimer&#39;s disease.&nbsp;</p><p>2 Isolated cases reported in post-marketing experience.&nbsp;</p><p>Alzheimer&#39;s disease has been associated with depression, suicidal ideation and suicide. In post-marketing experience these reactions have been reported in patients treated with&nbsp;Zementa.&nbsp;</p><p>Reporting of suspected adverse reactions&nbsp;</p><p>Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp; &nbsp; &nbsp; &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Only limited experience with overdose is available from clinical studies and post-marketing experience.&nbsp;</p><p>Symptoms&nbsp;</p><p>Relative large overdoses (200 mg and 105 mg/day for 3 days, respectively) have been associated with either only symptoms of tiredness, weakness and/or&nbsp;diarrhoea&nbsp;or no symptoms. In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination, and gait disturbance) and/or of gastrointestinal origin (vomiting and&nbsp;diarrhoea).&nbsp;</p><p>In the most extreme case of overdose, the patient survived the oral intake of a total of 2000 mg&nbsp;memantine&nbsp;with effects on the central nervous system (coma for 10 days, and later diplopia and agitation). The patient received symptomatic treatment and plasmapheresis. The patient recovered without permanent sequelae.&nbsp;</p><p>In another case of a large overdose, the patient also survived and recovered. The patient had received 400 mg&nbsp;memantine&nbsp;orally. The patient experienced central nervous system symptoms such as restlessness, psychosis, visual hallucinations,&nbsp;proconvulsiveness, somnolence, stupor, and unconsciousness.&nbsp;</p><p>Treatment&nbsp;</p><p>In the event of overdose, treatment should be symptomatic. No specific antidote for intoxication or overdose is available. Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbo&nbsp;medicinalis&nbsp;(interruption of potential&nbsp;entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate.&nbsp;</p><p>In case of signs and symptoms of general central nervous system (CNS) overstimulation, careful symptomatic clinical treatment should be considered.&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic&nbsp;group:&nbsp;Psychoanaleptics. Other Anti-dementia drugs, ATC code: N06DX01.&nbsp;</p><p>There is increasing evidence that malfunctioning of glutamatergic neurotransmission, in particular at NMDA-receptors, contributes to both&nbsp;expression&nbsp;of symptoms and disease progression in neurodegenerative dementia.&nbsp;</p><p>Memantine&nbsp;is a voltage-dependent, moderate-affinity uncompetitive NMDA-receptor antagonist. It modulates the effects of pathologically elevated tonic levels of glutamate that may lead to neuronal dysfunction.&nbsp;</p><p>Clinical studies&nbsp;</p><p>A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer&#39;s disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients. The study showed beneficial effects of&nbsp;memantine&nbsp;treatment in comparison to placebo at 6 months (observed cases analysis for the clinician&acute;s interview based impression of change (CIBIC-plus): p=0.025; Alzheimer&#39;s disease cooperative study &ndash; activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).&nbsp;</p><p>A pivotal monotherapy study of&nbsp;memantine&nbsp;in the treatment of mild to moderate Alzheimer&#39;s disease (MMSE total scores at baseline of 10 to 22) included 403 patients.&nbsp;Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer&#39;s disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 (last observation carried forward (LOCF)). In another monotherapy study in mild to moderate Alzheimer&#39;s disease a total of 470 patients (MMSE total scores at baseline of 11-23) were&nbsp;randomised. In the prospectively defined primary analysis statistical significance was not reached at the primary efficacy endpoint at week 24.&nbsp;</p><p>A meta-analysis of patients with moderate to severe Alzheimer&#39;s disease (MMSE total scores &lt; 20) from the six phase III, placebo-controlled, 6-month studies (including monotherapy studies and studies with patients on a stable dose of acetylcholinesterase inhibitors) showed that there was a statistically significant effect in&nbsp;favour&nbsp;of&nbsp;memantine&nbsp;treatment for the cognitive, global, and functional domains. When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of&nbsp;memantine&nbsp;in preventing worsening, as twice as many placebo-treated patients as&nbsp;memantine-treated patients showed worsening in all three domains (21% vs. 11%, p&lt;0.0001).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption&nbsp;</p><p>Memantine&nbsp;has an absolute bioavailability of approximately 100%.&nbsp;Tmax is between 3 and 8 hours. There is no indication that food influences the absorption of&nbsp;memantine.&nbsp;</p><p>Distribution&nbsp;</p><p>Daily doses of 20 mg lead to steady-state plasma concentrations of&nbsp;memantine&nbsp;ranging from 70 to 150 ng/ml (0.5 - 1 &micro;mol) with large&nbsp;interindividual&nbsp;variations. When daily doses of 5 to 30 mg were administered, a mean cerebrospinal fluid (CSF)/serum ratio of 0.52 was calculated. The volume of distribution is around 10 l/kg. About 45% of&nbsp;memantine&nbsp;is bound to plasma-proteins.&nbsp;</p><p>Biotransformation&nbsp;</p><p>In man, about 80% of the circulating&nbsp;memantine-related material is present as the parent compound. Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4- and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane. None of these metabolites exhibit NMDA-antagonistic activity. No cytochrome P 450&nbsp;catalysed&nbsp;metabolism has been detected in vitro.&nbsp;</p><p>In a study using orally administered 14C-memantine, a mean of 84% of the dose was recovered within 20 days, more than 99% being excreted&nbsp;renally.&nbsp;</p><p>Elimination&nbsp;</p><p>Memantine&nbsp;is eliminated in a&nbsp;monoexponential&nbsp;manner with a terminal t&frac12; of 60 to 100 hours. In volunteers with normal kidney function, total clearance (Cltot) amounts to 170 ml/min/1.73 m&sup2; and part of total renal clearance is achieved by tubular secretion.&nbsp;</p><p>Renal handling also involves tubular reabsorption, probably mediated by cation transport proteins. The renal elimination rate of&nbsp;memantine&nbsp;under alkaline urine conditions may be reduced by a factor of 7 to 9 (see section 4.4).&nbsp;Alkalisation&nbsp;of urine may result from drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or from the massive ingestion of&nbsp;alkalising&nbsp;gastric buffers.&nbsp;</p><p>Linearity&nbsp;</p><p>Studies in volunteers have demonstrated linear pharmacokinetics in the dose range of 10 to 40 mg.&nbsp;</p><p>Pharmacokinetic/pharmacodynamic&nbsp;relationship&nbsp;</p><p>At a dose of&nbsp;memantine&nbsp;of 20 mg per day the CSF levels match the&nbsp;ki-value (ki = inhibition constant) of&nbsp;memantine, which is 0.5 &micro;mol&nbsp;in human frontal cortex.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In short term studies in rats,&nbsp;memantine&nbsp;like other NMDA-antagonists have induced neuronal&nbsp;vacuolisation&nbsp;and necrosis (Olney lesions) only after doses leading to very high peak serum concentrations. Ataxia and other preclinical signs have preceded the&nbsp;vacuolisation&nbsp;and necrosis. As the effects have neither been observed in long term studies in rodents nor in non-rodents, the clinical relevance of these findings is unknown.&nbsp;</p><p>Ocular changes were inconsistently observed in repeat dose toxicity studies in rodents and dogs, but not in monkeys. Specific&nbsp;ophthalmoscopic&nbsp;examinations in clinical studies with&nbsp;memantine&nbsp;did not disclose any ocular changes.&nbsp;</p><p>Phospholipidosis&nbsp;in pulmonary macrophages due to accumulation of&nbsp;memantine&nbsp;in lysosomes was observed in rodents. This effect is known from other active substances with cationic amphiphilic properties. There is a possible relationship between this accumulation and the&nbsp;vacuolisation&nbsp;observed in lungs. This effect was only observed at high doses in rodents. The clinical relevance of these findings is unknown.&nbsp;</p><p>No genotoxicity has been observed following testing of&nbsp;memantine&nbsp;in standard assays. There was no evidence of any carcinogenicity in life long studies in mice and rats.&nbsp;Memantine&nbsp;was not teratogenic in rats and rabbits, even at maternally toxic doses, and no adverse effects of&nbsp;memantine&nbsp;were noted on fertility. In rats,&nbsp;foetal&nbsp;growth reduction was noted at exposure levels, which are identical or slightly higher than at human exposure.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core:&nbsp;Microcrystalline Cellulose&nbsp;(Avicel&nbsp;pH 102), Lactose NF Fast Flow,&nbsp;Croscarmellose&nbsp;Sodium Type A, Colloidal Silicon Dioxide.&nbsp;<br />&nbsp;</p><p>Tablet coating:&nbsp;Hydroxypropyl&nbsp;Methylcellulose, Titanium Dioxide pharma grade, Purified Talc, Polyethylene Glycol MW 6000, Purified Water (10mg) Iron Oxide Yellow, (20mg) Iron Oxide Red.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:593px"><tbody><tr><td style="vertical-align:top"><p>Not applicable.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>White Opaque PVC/PE/PVDC with hard tempered aluminum foil lid.&nbsp;</p><p>Each pack contains 30 film coated tablets.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:325px"><tbody><tr><td style="vertical-align:top"><p>No Special Requirements</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO 

Al-Qassim Pharmaceutical Plant 

Saudi Arabia 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2020. 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>